Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
US8846732B2 · kind B2 · utility
2Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 6, 2010 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Mar 3, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second portion of the SRB without directly killing the second portion of the SRB. The treatment of SRB with both a biocide and a metabolic inhibitor provides effective biogenic sulfide inhibition at significantly lower concentrations than would be required if the biocide or metabolic inhibitor was used alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.